Holdings of ARK Genomic Revolution ETF
ARK ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 1.6B $ including 1.6B $ in equities, 99.6 %
- Positions
- 32 in 3 countries
- Top ten
- 59.1 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | 10X Genomics Inc | 3,094,931 | 146.3M $ | 9.39 % |
| 2 | TWIST BIOSCIENCE CORP | 1,314,736 | 120.4M $ | 7.73 % |
| 3 | Tempus AI Inc | 2,329,124 | 102.2M $ | 6.56 % |
| 4 | CRISPR Therapeutics AG | 2,039,540 | 97.9M $ | 6.29 % |
| 5 | Personalis Inc | 6,733,812 | 85.3M $ | 5.47 % |
| 6 | Absci Corp | 10,287,893 | 80M $ | 5.14 % |
| 7 | GUARDANT HEALTH INC | 455,885 | 73.8M $ | 4.74 % |
| 8 | Illumina Inc | 359,801 | 73.8M $ | 4.74 % |
| 9 | Eli Lilly & Co | 63,502 | 73M $ | 4.68 % |
| 10 | CareDx Inc | 1,531,579 | 66.9M $ | 4.30 % |
| 11 | NATERA INC | 240,145 | 64.3M $ | 4.13 % |
| 12 | Beam Therapeutics Inc | 2,304,800 | 58.8M $ | 3.78 % |
| 13 | COMPASS PATHWAYS PLC | 4,463,875 | 50.7M $ | 3.25 % |
| 14 | Recursion Pharmaceuticals Inc | 13,638,907 | 40.9M $ | 2.63 % |
| 15 | Adaptive Biotechnologies Corp | 1,774,756 | 40.1M $ | 2.57 % |
| 16 | Veracyte Inc | 856,120 | 39.7M $ | 2.55 % |
| 17 | Nurix Therapeutics Inc | 1,682,054 | 39M $ | 2.51 % |
| 18 | Butterfly Network Inc | 4,770,809 | 33.9M $ | 2.18 % |
| 19 | Schrodinger Inc/United States | 2,042,579 | 30.9M $ | 1.99 % |
| 20 | GeneDx Holdings Corp | 446,965 | 29.1M $ | 1.87 % |
| 21 | Intellia Therapeutics Inc | 2,667,062 | 28.5M $ | 1.83 % |
| 22 | IONIS PHARMACEUTICALS INC | 531,633 | 27.5M $ | 1.77 % |
| 23 | Alamar Biosciences Inc | 957,178 | 24.3M $ | 1.56 % |
| 24 | PRIME MEDICINE INC | 7,513,485 | 21.9M $ | 1.41 % |
| 25 | Generate Biomedicines Inc | 1,237,891 | 17.3M $ | 1.11 % |
| 26 | Arcturus Therapeutics Holdings Inc | 2,741,123 | 15.8M $ | 1.01 % |
| 27 | Cerus Corp | 7,223,126 | 15.5M $ | 1.00 % |
| 28 | 908 Devices Inc | 1,905,332 | 15.3M $ | 0.98 % |
| 29 | Pacific Biosciences of California Inc | 10,630,263 | 14.9M $ | 0.96 % |
| 30 | AtaiBeckley Inc | 1,644,325 | 11.8M $ | 0.76 % |
| 31 | SCRIBE THERAPEUTICS INC | 352,097 | 6.9M $ | 0.44 % |
| 32 | QUANTUM-SI INC | 6,760,803 | 4.8M $ | 0.31 % |
Sector breakdown
- Health care 15.4 %
- Unattributed 84.6 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 90.4 %
- Switzerland 6.3 %
- United Kingdom 3.3 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 30 | 1.4B $ | 90.43 % |
| 2 | Switzerland | 1 | 97.9M $ | 6.31 % |
| 3 | United Kingdom | 1 | 50.7M $ | 3.27 % |
Cite this page
Titelia. "Holdings of ARK Genomic Revolution ETF". https://titelia.com/en/funds/S000042975